 Kindred Biosciences, Inc. NASDAQ: KIN, Aprea Therapeutics, Inc. NASDAQ: APRE, Catabasis Pharmaceuticals, Inc. NASDAQ: CATB and Inhibikase Therapeutics, Inc. NASDAQ: IKT are among the biggest biopharma movers on Wednesday. Kindred Flies On Buyout: Kindred announced an agreement to be bought by Elanco Animal Health Incorporated NYSE: ELAN for 9.25 per share, or approximately 440 million. 